The Bionow Strategic Advisory Board is composed of senior individuals from across the North of England representing a cross-section of our membership and the sector as a whole. The Advisory Board advises Bionow offering sector relevant strategic advice and guidance.
The current membership of the Strategic Advisory Board is as follows:
- Chair: Mike Snowden, VP and Head of Discovery Science, AstraZeneca
- Graham Bond, Partner, RSM
- Allan Brown, Chief Operating Officer, QuantuMDx
- Linda Randall, Director, Process Sciences, Allergan Biologics
- Malcolm Jackson, Head of Institute, Institute of Ageing and Chronic Disease, University of Liverpool
- Chris Doherty, Alderley Park Site Director, MSP
- Paul Found, COO, Fujifilm Diosynth Biotechnologies
- John Goodacre, Faculty of Health and Medicine, Lancaster University
- Andy Gover, General Manager, Head of R&D, QIAGEN
- Catherine Headley, Head of Strategic Accounts, University of Manchester
- Andy Jones, Founder and Director, MedrusPharma Consulting
- Neil Murray, CEO, NDM Biotech
- Lloyd Payne, Executive Vice President, Evotec
- Dave Simpson, CEO, Glythera
- Joe de Sousa, Director Science and Technology, AstraZeneca
- John Stageman, Chair, Bionow
- Jane Theaker, Associate, Core Precision
- Simon Wallwork, Partner, Slater Heelis
Latest Jobs
